title: Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?
authors.forename: J
authors.initials: J
authors.lastname: Perkins
authors.forename: L
authors.initials: L
authors.lastname: Kaminer
authors.forename: M
authors.initials: M
authors.lastname: Kruskall
authors.forename: M
authors.initials: M
authors.lastname: Cannon
authors.forename: L
authors.initials: L
authors.lastname: Uhl
authors.forename: W
authors.initials: W
authors.lastname: Dzik
authors.forename: H
authors.initials: H
authors.lastname: Silver
authors.forename: M
authors.initials: M
authors.lastname: O'Neill
authors.forename: M
authors.initials: M
authors.lastname: Popovsky
authors.forename: K
authors.initials: K
authors.lastname: King
authors.forename: P
authors.initials: P
authors.lastname: Ness
authors.forename: J
authors.initials: J
authors.lastname: AuBuchon
authors.forename: A
authors.initials: A
authors.lastname: Shapiro
authors.forename: R
authors.initials: R
authors.lastname: Yomtovian
authors.forename: L D
authors.initials: LD
authors.lastname: Petz
mesh_terms: D001804:Blood Transfusion, Autologous / Q000191:economics / Q000331:legislation & jurisprudence*; D003140:Communicable Disease Control / Q000331:legislation & jurisprudence*; D003141:Communicable Diseases / Q000097:blood* / Q000175:diagnosis / Q000635:transmission; D004469:Economics, Hospital; D006801:Humans; D019300:Medical Errors; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration